Abstract:Daidzein is a water-insoluble phytoestrogenic isoflavone of the Leguminosae family, mainly found in soy and soy-derived foods. Daidzein has a broad spectrum of physiological and pharmacological functions. It has anti-cancer, anti-inflammatory, antioxidant, enzyme inhibitor properties and causes a decrease in low-density lipoprotein levels. Glioblastoma Multiforme (GBM) is the most common, rapidly progressing, and fatal primary brain tumor. It accounts for more than 51% of all gliomas. For this reason, much scientific research is being done to treat brain tumors. This study aims to prepare daidzein-loaded PLGA and PLGA-Gelucire® 44/14 nanoparticles for the treatment of GBM and to evaluate their characteristics, neurotoxicity, and cytotoxicity in vitro. The PLGA and PLGA-Gelucire® 44/14 nanoparticles were prepared by using the non-modified and modified emulsion-solvent diffusion method. The surface morphology, particle size, zeta potential (ZP), encapsulation efficiency (EE) and in vitro release characteristics of nanoparticles were investigated. Furthermore, FT-IR, DSC and SEM were used to characterize these systems. The neurotoxicity on neurons and cytotoxicity against the U-87 MG cell line of the chosen optimum nanoparticle formulations were evaluated. The mean particle size and ZP values of all prepared nanoparticles were a range of 198.52±7.04-672.78±70.95 nm (p≥0.05) and -14.70±0.36--0.50±0.34 mV (p≥0.05), respectively. SEM images of nanoparticles revealed their approximately spherical shape. The EE % values of nanoparticles were a range of % 35.79±3.43-84.85±2.20 (p≥0.05). The cumulative daidzein release from daidzein-loaded nanoparticle formulations was up to about 100 % at 19-37 days of release. It was found that the prepared nanoparticulate systems reduced the neurotoxic effects of daidzein and showed similar cytotoxic effects to those of daidzein (p0.05). The prepared nanoparticles are useful and promising systems for sustained release of daidzein, reduction of the neurotoxic effects of daidzein at high doses (200 μM and 300 μM) and maintaining of its cytotoxic activity against cancer cells.

FORMULATION AND IN VITRO EVALUATION OF POLY-(D, L-LACTIDE-CO-GLYCOLIDE) (PLGA) NANOPARTICLES OF ELLAGIC ACID AND ITS EFFECT ON HUMAN BREAST CANCER, MCF-7 CELL LINE.

PLLAGrafted Gelatin Amphiphilic Copolymer and Its SelfAssembled Nano Carrier for Anticancer Drug Delivery

Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines

Selective Targeting of the Novel CK-10 Nanoparticles to the MDA-MB-231 Breast Cancer Cells

Study on the preparation and activity of intelligent response poly(lactic-co-glycolic acid)-ss-polyethylene glycol copolymer micelles

Preparation of chelidonine highly loaded poly(lactide-co-glycolide)-based nanoparticles using a single emulsion method: Cytotoxic effect on MDA-MB-231 cell line

Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles

Fabrication, Characterization and Evaluation of Gallic Acid-Encapsulated Curdlan Gum Nanoparticles with Potential Application for Breast Cancer Treatment

Preparation and characterisation of gallic acid loaded carboxymethyl chitosan nanoparticles as drug delivery system for cancer treatment

Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells

Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.

Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors

Nanoparticle Formulation of Poly(ɛ-Caprolactone-co-lactide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cervical Cancer Treatment

Folate Receptor-Targeted Nanodelivery of Apigenin in Breast Cancer: Formulation Development, Characterization and In Vitro Evaluation

Amphiphilic Block Copolymer Poly (Acrylic Acid)-B-Polycaprolactone as a Novel pH-sensitive Nanocarrier for Anti-Cancer Drugs Delivery: In-vitro and In-vivo Evaluation.

Multicomponent Polymeric Nanoparticles Enhancing Intracellular Drug Release in Cancer Cells

5-Fluorouracil-Loaded PLGA Nanoparticles: Formulation, Physicochemical Characterisation, and In VitroAnti-Cancer Activity

Preparation and In Vitro Evaluation of Daidzein-Loaded Nanoparticulate Systems

Optimization (Central Composite Design) and Validation of HPLC Method for Investigation of Emtricitabine Loaded Poly(lactic-co-glycolic acid) Nanoparticles: In Vitro Drug Release and In Vivo Pharmacokinetic Studies

Good's Buffer Based Highly Biocompatible Ionic Liquid Modified PLGA Nanoparticles for the Selective Uptake in Cancer Cells

Preparation of anti-HER-2 antibody PLGA polymer nano- ultrasound contrast agent In vitro targeting experiment